|
Skyepharma Confirms 2010 Guidance, Sees Fall In 2011 Revenues
Wall Street Journal In August, SkyePharma PLC's partner Abbott Laboratories (ABT) pulled out of development of the asthma treatment due to the lack of progress. |
View full post on asthma – Google News